Brain cancer prediction has reached new heights with the advent of artificial intelligence, particularly in assessing risks associated with pediatric brain tumors.Recent studies demonstrate how AI tools can significantly improve the accuracy of predicting glioma risk and tumor recurrence, surpassing traditional medical methodologies.